These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 1382434)

  • 21. Preferential usage of T cell antigen receptor V region gene segment V beta 5.1 by Borrelia burgdorferi antigen-reactive T cell clones isolated from a patient with Lyme disease.
    Lahesmaa R; Shanafelt MC; Allsup A; Soderberg C; Anzola J; Freitas V; Turck C; Steinman L; Peltz G
    J Immunol; 1993 May; 150(9):4125-35. PubMed ID: 7682589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frequency and specificity of antibodies that crossreact with Borrelia burgdorferi antigens.
    Fawcett PT; Gibney KM; Rose CD; Dubbs SB; Doughty RA
    J Rheumatol; 1992 Apr; 19(4):582-7. PubMed ID: 1593581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular mimicry and Lyme borreliosis: a shared antigenic determinant between Borrelia burgdorferi and human tissue.
    Aberer E; Brunner C; Suchanek G; Klade H; Barbour A; Stanek G; Lassmann H
    Ann Neurol; 1989 Dec; 26(6):732-7. PubMed ID: 2481425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular mimicry and Lyme borreliosis.
    Sigal LH
    Ann Neurol; 1990 Aug; 28(2):195-6. PubMed ID: 1699473
    [No Abstract]   [Full Text] [Related]  

  • 25. Immunoreactive epitopes on an expressed recombinant flagellar protein of Borrelia burgdorferi.
    Collins C; Peltz G
    Infect Immun; 1991 Feb; 59(2):514-20. PubMed ID: 1702766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunologic and structural characterization of the dominant 66- to 73-kDa antigens of Borrelia burgdorferi.
    Luft BJ; Gorevic PD; Jiang W; Munoz P; Dattwyler RJ
    J Immunol; 1991 Apr; 146(8):2776-82. PubMed ID: 2016526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural occurrence and characterization of the Lyme disease spirochete, Borrelia burgdorferi, in cotton rats (Sigmodon hispidus) from Georgia and Florida.
    Oliver JH; Chandler FW; James AM; Sanders FH; Hutcheson HJ; Huey LO; McGuire BS; Lane RS
    J Parasitol; 1995 Feb; 81(1):30-6. PubMed ID: 7876974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of flagellin-enriched antigens in a rapid, simple and specific quantitative enzyme immunoassay for Lyme disease antibodies in human serum samples.
    Lin TM; Schubert CM; Shih FF; Ahmad P; Lopez M; Horst H
    J Immunoassay; 1991; 12(3):325-46. PubMed ID: 1939664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epitopes on the outer surface protein A of Borrelia burgdorferi recognized by antibodies and T cells of patients with Lyme disease.
    Shanafelt MC; Anzola J; Soderberg C; Yssel H; Turck CW; Peltz G
    J Immunol; 1992 Jan; 148(1):218-24. PubMed ID: 1370170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cross-antigenicity between the major surface proteins (ospA and ospB) and other proteins of Borrelia burgdorferi.
    Jiang W; Luft BJ; Munoz P; Dattwyler RJ; Gorevic PD
    J Immunol; 1990 Jan; 144(1):284-9. PubMed ID: 2295795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serologic response to the Borrelia burgdorferi flagellin demonstrates an epitope common to a neuroblastoma cell line.
    Fikrig E; Berland R; Chen M; Williams S; Sigal LH; Flavell RA
    Proc Natl Acad Sci U S A; 1993 Jan; 90(1):183-7. PubMed ID: 7678336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies on OspA: a source of new paradigms in Lyme disease research.
    Philipp MT
    Trends Microbiol; 1998 Feb; 6(2):44-7. PubMed ID: 9507636
    [No Abstract]   [Full Text] [Related]  

  • 33. [Borrelia burgdorferi infection. I. Aspects of basic research, current approach for diagnosis and therapy].
    Kramer MD; Wallich R; Schaible UE; Zimmer G; Simon MM
    Hautarzt; 1990 Dec; 41(12):648-57. PubMed ID: 2089023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Presentation of peptide antigens as albumin conjugates for use in detection of serum antibodies by enzyme-linked immunosorbent assay.
    Yu Z; Carter JM; Huang SY; Lackland H; Sigal LH; Stein S
    Bioconjug Chem; 1996; 7(3):338-42. PubMed ID: 8816957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of an immunoreactive 93-kDa core protein of Borrelia burgdorferi with a human IgG monoclonal antibody.
    Volkman DJ; Luft BJ; Gorevic PD; Schultz J; Padovano L
    J Immunol; 1991 May; 146(9):3177-82. PubMed ID: 2016542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A monoclonal antibody to Borrelia burgdorferi flagellin modifies neuroblastoma cell neuritogenesis in vitro: a possible role for autoimmunity in the neuropathy of Lyme disease.
    Sigal LH; Williams S
    Infect Immun; 1997 May; 65(5):1722-8. PubMed ID: 9125553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antigens of Lyme disease of spirochaete Borrelia burgdorferi inhibits antigen or mitogen-induced lymphocyte proliferation.
    Chiao JW; Pavia C; Riley M; Altmann-Lasekan W; Abolhassani M; Liegner K; Mittelman A
    FEMS Immunol Med Microbiol; 1994 Feb; 8(2):151-5. PubMed ID: 8173554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD4+ Th2 T cells elicited by immunization confer protective immunity to experimental Borrelia burgdorferi infection.
    Rao TD; Fischer A; Frey AB
    Ann N Y Acad Sci; 1994 Aug; 730():364-6. PubMed ID: 7915895
    [No Abstract]   [Full Text] [Related]  

  • 39. Lyme disease in transgenic mice expressing the Borrelia burgdorferi flagellin epitope implicated in human neuroborreliosis.
    Fikrig E; Barthold SW
    FEMS Microbiol Lett; 1997 Mar; 148(2):137-43. PubMed ID: 9084140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Seronegative Lyme disease.
    Steere AC
    JAMA; 1993 Sep; 270(11):1369. PubMed ID: 8360974
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.